Navigation Links
ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Date:10/29/2008

upply or distribution interruptions, including but not

limited to our ability to acquire adequate supplies of Vancocin and

Cinryze to meet demand for the product;

-- changes in prescribing or procedural practices of infectious disease,

gastroenterology and internal medicine doctors, including off-label

prescribing of other products;

-- the timing of regulatory submissions and approvals;

-- actions by the FDA, EMEA and the Internal Revenue Service or other

government regulatory agencies;

-- decreases in the rate of infections for which Vancocin is prescribed;

-- decrease in the sensitivity of the relevant bacteria to Vancocin;

-- our ability to successfully integrate the business of Lev

Pharmaceuticals, Inc.;

-- the timing and results of anticipated events in the Company's CMV and

NTCD programs; and

-- the timing and nature of potential business development activities

related to the Company's efforts to expand its current portfolio

through in-licensing or other means of acquiring products in clinical

development or marketed products.

There can be no assurance that FDA or EMEA will not require additional or unanticipated studies or clinical trial outcomes before granting regulatory approval of any of the company's product candidates, or that the company will be successful in gaining regulatory approval of any of its product candidates.

These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2008, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-loo
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
2. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
4. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Augments Senior Management
7. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
8. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
9. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. ViroPharma to Present at the Maxim Group First Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... Viejo, California (PRWEB) September 21, 2014 ... X plugins have announced a new transition plugin ... “Transpack Vol. 3 delivers high quality transitions that will ... project,” said Christina Austin, CEO of Pixel Film Studios. ... 3 is a definite game changer.” , Transpack Vol. ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... party dresses . In addition, the company has launched a ... the promotion is to benefit all of its big fans. ... store now. , Along with beautiful party dresses, the ... has recently released its new sexy short prom outfits and ...
(Date:9/20/2014)... David Cooke presented two scientific posters at ... at the clinical benefits of MPI gated studies with ... In conjunction with colleagues at Emory University, Cooke studied ... by echo (>50%). Each patient had same-day 99mTc low-dose ... Emory Toolbox 4.0 was used to analyze the ...
(Date:9/20/2014)... Ticket Down is a reputable source for ... ticket exchange is offering their customer appreciation promo code ARIANA-2015 ... step in the entertainment business. The 21-year-old from Boca Raton, ... entertainment business, but is closing in on “Pop Diva” status. ... will hit the road next year on the “Honeymoon Tour,” ...
(Date:9/20/2014)... News) -- The avian flu that killed 160 harbor ... through respiratory drops and therefore poses a potential threat ... no human illnesses have been linked to the harbor ... have discovered natural mutations to the avian H3N8 seal ... air in droplets. Current seasonal flu vaccines wouldn,t ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Avian Flu In Harbor Seals Could Infect People 2
... After only four years of problem drinking, a significant decrease ... can be seen. This is the system that regulates such ... before a corresponding decrease is seen in men. This is ... of Psychology and the Sahlgrenska Academy at the University of ...
... , TUESDAY, Nov. 15 (HealthDay News) --,Pneumonia is the ... The researchers also revealed that most infections occur about ... previously thought. They are slated to present their findings Tuesday ... Fla. "It,s not what we expected to find," study ...
... Sophia Antipolis, 15 November 2011: People taking anti-psychotic drugs and ... an acute coronary event of a fatal arrhythmia than the ... the European Heart Journal .1 The study showed ... was associated with an even greater risk of sudden cardiac ...
... techniques on toy animals before having to perform operations on ... same time, the use of laboratory animals is minimised. This ... the Faculty of Life Sciences at the University of Copenhagen. ... ,teddy laboratory, strengthens learning and the teaching environment. ...
... Steven Reinberg HealthDay Reporter , MONDAY, Nov. 14 ... of the contraceptive pill over the past 40 years, the ... responsible for the increased incidence of prostate cancer around the ... cause various cancers, and the widespread use of the pill ...
... Among patients who experienced an ischemic stroke, systolic blood ... than 140 mm Hg, were associated with an increased risk ... November 16 issue of JAMA , a theme issue ... to coincide with the American Heart Association Scientific Sessions. ...
Cached Medicine News:Health News:Pneumonia Most Common Infection After Heart Surgery 2Health News:EHJ paper underlines need for improved links between cardiologists and psychiatrists 2Health News:EHJ paper underlines need for improved links between cardiologists and psychiatrists 3Health News:Surgery on toy animals lessens anxiety of veterinary students 2Health News:Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk? 2Health News:Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk? 3Health News:Study evaluates 'normal range' systolic bp levels after ischemic stroke and risk of recurrent stroke 2
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy stores ... opened in Memphis and Cordova ... in Springfield on September 24 and a ... open October 22.  MinuteClinic is the largest and fastest growing provider ... . The Memphis -area clinics join ...
(Date:9/19/2014)... According to market research ... Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical ... & Geography - Global Trends & Forecast to ... lyophilization market on the basis of various types, ... the market size of each of these segments ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... 2012  Celebrity chef Spike Mendelsohn knows all too well the ... a person with acid reflux disease (ARD). But while he,s ... had to learn how to turn down the heat on ... about the importance of managing heartburn symptoms of ARD, including ...
... 2, 2012 Reportlinker.com announces that a new ... Ophthalmic Drugs: World Market ... Report Details How ... ophthalmic drug industry What are the ...
Cached Medicine Technology:Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 2Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 3Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 4Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 5Ophthalmic Drugs: World Market Prospects 2012-2022 2Ophthalmic Drugs: World Market Prospects 2012-2022 3Ophthalmic Drugs: World Market Prospects 2012-2022 4Ophthalmic Drugs: World Market Prospects 2012-2022 5Ophthalmic Drugs: World Market Prospects 2012-2022 6Ophthalmic Drugs: World Market Prospects 2012-2022 7Ophthalmic Drugs: World Market Prospects 2012-2022 8Ophthalmic Drugs: World Market Prospects 2012-2022 9Ophthalmic Drugs: World Market Prospects 2012-2022 10Ophthalmic Drugs: World Market Prospects 2012-2022 11Ophthalmic Drugs: World Market Prospects 2012-2022 12Ophthalmic Drugs: World Market Prospects 2012-2022 13Ophthalmic Drugs: World Market Prospects 2012-2022 14Ophthalmic Drugs: World Market Prospects 2012-2022 15
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
... therapeutic, expandable turning surface for the BariMaxx™ ... Prevention and treatment of pressure ulcers, Large ... patients using a statuc mattress that would ... whose body weight and size pose a ...
... The BariMaxx™ is a full-featured healthcare bed ... for the care and management of larger ... to 1000 lbs. ,Large patients at risk ... in excess of 1000 lbs. (including accessories), ...
Medicine Products: